These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 17578171)

  • 1. [How corticoids, growth hormone and oestrogens influence lipids and atherosclerosis].
    Marek J; Hána V; Krsek M
    Vnitr Lek; 2007 Apr; 53(4):386-90. PubMed ID: 17578171
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Secondary diabetes associated with principal endocrinopathies: the impact of new treatment modalities.
    Resmini E; Minuto F; Colao A; Ferone D
    Acta Diabetol; 2009 Jun; 46(2):85-95. PubMed ID: 19322513
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hormones and cardiovascular disease: a shift in paradigm with clinical consequences?
    van Zaane B; Reuwer AQ; Büller HR; Kastelein JJ; Gerdes VE; Twickler MT
    Semin Thromb Hemost; 2009 Jul; 35(5):478-87. PubMed ID: 19739038
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of 5 years of growth hormone replacement therapy on cardiovascular risk factors in growth hormone-deficient adults.
    Cenci MC; Conceição FL; Soares DV; Spina LD; Brasil RR; Lobo PM; Michmacher E; Vaisman M
    Metabolism; 2008 Jan; 57(1):121-9. PubMed ID: 18078869
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypertension and dyslipidaemia in obesity and insulin resistance: pathophysiology, impact on atherosclerotic disease and pharmacotherapy.
    Chapman MJ; Sposito AC
    Pharmacol Ther; 2008 Mar; 117(3):354-73. PubMed ID: 18215759
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Hormone replacement therapy and cardiovascular risk in postmenopausal women].
    Kovacev-Zavisić B; Icin T; Kovacev N
    Med Pregl; 2009; 62 Suppl 3():85-90. PubMed ID: 19702123
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Hypertension in postmenopausal women --selected pathomechanisms].
    Pośnik-Urbańska A; Kawecka-Jaszcz K
    Przegl Lek; 2006; 63(12):1313-7. PubMed ID: 17642147
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Understanding the oestrogen action in experimental and clinical atherosclerosis.
    Arnal JF; Douin-Echinard V; Brouchet L; Tremollières F; Laurell H; Lenfant F; Gadeau AP; Guery JC; Gourdy P
    Fundam Clin Pharmacol; 2006 Dec; 20(6):539-48. PubMed ID: 17109647
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Melancholic depression and abdominal fat distribution: a mini-review.
    Mann JN; Thakore JH
    Stress; 1999 Aug; 3(1):1-15. PubMed ID: 19016189
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thyroid diseases, dyslipidemia and cardiovascular pathology.
    Neves C; Alves M; Medina JL; Delgado JL
    Rev Port Cardiol; 2008 Oct; 27(10):1211-36. PubMed ID: 19178025
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of phyto-oestrogens on tissues.
    Anderson JJ; Anthony M; Messina M; Garne SC
    Nutr Res Rev; 1999 Jun; 12(1):75-116. PubMed ID: 19087447
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The predictive role of atherogenic dyslipidemia in subjects with non-coronary atherosclerosis.
    Berneis K; Rizzo M; Spinas GA; Di Lorenzo G; Di Fede G; Pepe I; Pernice V; Rini GB
    Clin Chim Acta; 2009 Aug; 406(1-2):36-40. PubMed ID: 19433079
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of modified transdermal hormone replacement therapy on the concentrations of hormones, growth factors, and bone mineral density in women with osteopenia.
    Stanosz S; Zochowska E; Safranow K; Sieja K; Stanosz M
    Metabolism; 2009 Jan; 58(1):1-7. PubMed ID: 19059524
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The importance of recognizing and treating low levels of high-density lipoprotein cholesterol: a new era in atherosclerosis management.
    Cardenas GA; Lavie CJ; Cardenas V; Milani RV; McCullough PA
    Rev Cardiovasc Med; 2008; 9(4):239-58. PubMed ID: 19122582
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Associations of dyslipidemias from childhood to adulthood with carotid intima-media thickness, elasticity, and brachial flow-mediated dilatation in adulthood: the Cardiovascular Risk in Young Finns Study.
    Juonala M; Viikari JS; Rönnemaa T; Marniemi J; Jula A; Loo BM; Raitakari OT
    Arterioscler Thromb Vasc Biol; 2008 May; 28(5):1012-7. PubMed ID: 18309111
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adult-onset growth hormone deficiency: causes, complications and treatment options.
    Mathioudakis N; Salvatori R
    Curr Opin Endocrinol Diabetes Obes; 2008 Aug; 15(4):352-8. PubMed ID: 18594276
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overview of prevention and treatment of atherosclerosis with lipid-altering therapy for pharmacy directors.
    Davidson MH
    Am J Manag Care; 2007 Dec; 13 Suppl 10():S260-9. PubMed ID: 18095776
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PPAR agonists and the metabolic syndrome.
    Staels B
    Therapie; 2007; 62(4):319-26. PubMed ID: 17983557
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Diabetic dyslipoproteinemia: beyond LDL].
    Merkel M
    Dtsch Med Wochenschr; 2009 May; 134(20):1067-73. PubMed ID: 19421932
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effects of garlic allicor tablets on lipid metabolism and risk of fatal cardiovascular complications in patients with atherogenic dyslipoproteinemia].
    Gromnatskiĭ NI; Sereditskaia ZhE; Lazareva NV; Sereditskiĭ AV; Annenkova GV
    Vopr Pitan; 2007; 76(6):60-4. PubMed ID: 18219944
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.